Genmab — Maj 2024
-
Fredagens aktier: Zealand og Genmab sendt i dørken mens Mærsk stak af efter ratetal https://proinvestor.com/investornyt/1164225/fredagens-aktier-zealand-og-genmab-sendt-i-dorken-mens-maersk-stak-af-efter-ratetal
-
It will never be fully 1 : 1, even when market caps are reasonably similar like these 2. BioNTech lost 2.1% of ~23.36bn = $490mn, Genmab 4.9% of 18.07bn = $885mn. Trading volume was surprisingly similar in $ volume, $125 – $135mn on the main exchanges. But the investors in both companies will be different people with different ideas. And Biontech also had other abstracts. Markets are not perfect. They both trade near their 2021 lows by the way, but Biontech’s all time high was x4 todays price..
-
Synes nu godt at man kan sammenligne Genmab og Biontech..... Der i 2022, hvor Biontech aktien stak helt af - var det ikke Corona vaccinen der fik aktien til dette?..... Så min tese er stadig at det er usikkerheden omkring CD38 der spøger, - og puha, hvor bliver det en gyser for kursudviklingen, når der er et halvt år endnu. Før vi på den ene eller anden måde får den usikkerhed ud af verden
-
Godmorgen.
-
Godmorgen
-
Sanofi's Sarclisa Granted FDA Priority Review For Transplant-Ineligible Multiple Myeloma Treatment https://proinvestor.com/investornyt/1164760/sanofis-sarclisa-granted-fda-priority-review-for-transplant-ineligible-multiple-myeloma-treatment
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind